List of works - Chandana A Reddy

30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.

scientific article published on 08 July 2014

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

scientific article published on 09 July 2015

A Histologic Basis for the Efficacy of SBRT to the lung

scientific article published on 20 December 2016

A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.

scientific article published on 24 April 2017

A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience

scientific article published on 01 August 2009

A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.

scientific article

A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.

scientific article published on 7 February 2017

A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer ⬇️

scientific article published on June 2, 2012

A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy

scientific article published on 01 December 2004

Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis

scientific article published on 18 March 2017

Adjuvant versus neoadjuvant androgen deprivation with radiotherapy for prostate cancer: does sequencing matter?

scientific article published on 31 December 2014

Aggressiveness of familial prostate cancer

scientific article published on 01 July 2006

Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence

scientific article published on 5 October 2014

Association of body mass index with prostate cancer biochemical failure.

scientific article

Brain metastases from gynecological cancers: factors that affect overall survival.

scientific article published in August 2002

Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.

scientific article

Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancer.

scientific article published on January 2008

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study

scientific article published on 05 April 2018

Clinical and Radiographic Outcomes From Repeat Whole-brain Radiation Therapy for Brain Metastases in the Age of Stereotactic Radiosurgery

scientific article published on 01 June 2016

Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer.

scientific article

Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.

scientific article published in July 2009

Consent form heterogeneity in cancer trials: the cooperative group and institutional review board gap.

scientific article published on July 2013

Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery

scientific article published on 26 May 2012

Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience

scientific article

Departmental Workload and Physician Errors in Radiation Oncology.

scientific article published on 28 June 2016

Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes

scientific article

Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?

scientific article published in January 2002

Dosimetric differences between local failure and local controlled non-small cell lung cancer patients treated with stereotactic body radiotherapy: A matched-pair study

scientific article

Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold model

scientific article published in July 2004

Editorial comment

Effect of Prostate-specific Antigen Screening on Metastatic Disease Burden 10 Years After Diagnosis ⬇️

scientific article published on August 1, 2012

Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy

scientific article published on 01 January 2003

Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer

scientific article published on 08 November 2007

Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity

scientific article published on 08 July 2014

Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database

scientific article

External beam radiotherapy followed by 90Y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma.

scientific article

Five year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation therapy or permanent seed implantation

scientific article published on 08 April 2010

HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study

scientific article

High-dose-rate endobronchial brachytherapy for recurrent airway obstruction from hyperplastic granulation tissue

scientific article published on 29 September 2007

Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer

scientific article published on 01 February 2000

Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience

scientific article published on 04 June 2007

Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes

scientific article published on 19 September 2005

Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus-negative head and neck cancer

scientific article published on 02 September 2015

Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy

scientific article published on 05 May 2012

Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone.

scientific article published on 14 June 2016

Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate

scientific article published on 01 January 2000

Improved biochemical relapse-free survival for patients with large/wide glands treated with prostate seed implantation for localized adenocarcinoma of prostate.

scientific article published on December 2006

Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome

scientific article published on 01 November 2003

In Regard to Viani et al.

scientific article published in July 2016

In Reply to Morris and Tyldesley.

scientific article

Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy

scientific article published on 29 May 2015

Influence of zonal dosimetry on prostate brachytherapy outcomes

scientific article

Informed consent conversations and documents: A quantitative comparison.

scientific article

Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.

scientific article

Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience.

scientific article published on 2 November 2006

Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience.

scientific article

Late toxicity after intensity modulated and image guided radiation therapy for localized prostate cancer and post-prostatectomy patients.

scientific article

Long-Term Efficacy and Toxicity of Low-Dose-Rate ¹²⁵I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer.

scientific article published on 8 May 2015

Lung stereotactic body radiation therapy: regional nodal failure is not predicted by tumor size.

scientific article

Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases

scientific article published on 08 October 2011

Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.

scientific article published on 14 May 2010

Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial Design.

scientific article published on 20 July 2016

Modern outcomes of inflammatory breast cancer.

scientific article

Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.

scientific article published on April 2004

Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity

scientific article published on 13 March 2013

Never too old: A single-institution experience of stereotactic body radiation therapy for patients 90 years and older with early stage lung cancer.

scientific article published on 29 June 2017

No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients

scientific article published on 01 July 2000

Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy

scientific article

Outcomes for prostate glands >60 cc treated with low-dose-rate brachytherapy

scientific article

Outcomes in Organ Transplant Recipients With Prostate Cancer Treated With Radiotherapy

scientific article published on 18 October 2018

PSA bounce and biochemical failure after brachytherapy for prostate cancer: a study of 820 patients with a minimum of 3 years of follow-up

scientific article published on 18 June 2010

PSA bounce predicts early success in patients with permanent iodine-125 prostate implant

scientific article published on 01 January 2004

PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time

scientific article published on 06 October 2005

Perineural invasion on prostate needle biopsy does not predict biochemical failure following brachytherapy for prostate cancer

scientific article published on 20 March 2006

Postoperative single-fraction radiation for prevention of heterotopic ossification of the elbow

scientific article published on 01 August 2010

Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific Mortality

scientific article published on 17 July 2016

Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.

scientific article published on 9 May 2015

Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)

scientific article published on 06 February 2011

Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer

scientific article published on 11 February 2017

Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer

scientific article published on 01 July 2002

Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate can

scientific article published on 01 August 2002

Prophylactic urethral stenting with Memokath® 028SW in prostate cancer patients undergoing prostate 125I seed implants: phase I/II study

scientific article published on 31 March 2011

Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6, and pretreatment prostate-specific antigen < or = 10)

scientific article published on 01 July 2001

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer

scientific article published in March 2018

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

scientific article published on January 2004

Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?

scientific article published in March 2004

Recursive partitioning analysis is predictive of overall survival for patients undergoing spine stereotactic radiosurgery.

scientific article published on 3 January 2018

Redefining High-Risk Prostate Cancer Based on Distant Metastases and Mortality After High-Dose Radiotherapy With Androgen Deprivation Therapy ⬇️

scientific article published on June 12, 2011

Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-Institution Cohort Study by the MIRI Collaborative.

scientific article published on 17 June 2017

Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.

scientific article published on 27 February 2014

Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis

scientific article published on 17 April 2015

Safety and efficacy of salvage low-dose-rate brachytherapy for prostate bed recurrences following radical prostatectomy.

scientific article published on August 2015

Secondary Urethral Malignancies Following Prostate Brachytherapy

scientific article published on 4 September 2017

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life ⬇️

scientific article published on November 15, 2001

Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma ⬇️

scientific article published on September 28, 2012

Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone.

scientific article

Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer

scientific article

Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases

scientific article published on 01 October 2018

Survival Among Men With Clinically Localized Prostate Cancer Treated With Radical Prostatectomy or Radiation Therapy in the Prostate Specific Antigen Era

scientific article published on 14 February 2012

Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer

scientific article published on 02 February 2019

The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy.

scientific article published on 27 May 2015

The efficacy of external beam radiotherapy and stereotactic body radiotherapy for painful spinal metastases from renal cell carcinoma

scientific article published on 15 February 2012

The importance of serum prostate-specific antigen testing frequency in assessing biochemical and clinical failure after prostate cancer treatment

scientific article published on 28 October 2009

The role of adjuvant radiation therapy in the treatment of spinal myxopapillary ependymomas.

scientific article

The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma

scientific article published on 01 July 2000

Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy.

scientific article

Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution ⬇️

scientific article published on May 6, 2011

Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer

scientific article published on 28 October 2017

Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer

scientific article published on 18 September 2006

Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis.

scientific article

Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis

scientific article published in December 2017

Workflow enhancement (WE) improves safety in radiation oncology: putting the WE and team together

scientific article published on 28 March 2014

List of works by Chandana A Reddy

30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

A Histologic Basis for the Efficacy of SBRT to the lung

A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.

A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience

A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.

A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.

A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer ⬇️

A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy

Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis

Adjuvant versus neoadjuvant androgen deprivation with radiotherapy for prostate cancer: does sequencing matter?

Aggressiveness of familial prostate cancer

Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence

Association of body mass index with prostate cancer biochemical failure.

Brain metastases from gynecological cancers: factors that affect overall survival.

Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.

Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancer.

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study

Clinical and Radiographic Outcomes From Repeat Whole-brain Radiation Therapy for Brain Metastases in the Age of Stereotactic Radiosurgery

Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer.

Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.

Consent form heterogeneity in cancer trials: the cooperative group and institutional review board gap.

Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery

Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience

Departmental Workload and Physician Errors in Radiation Oncology.

Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes

Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?

Dosimetric differences between local failure and local controlled non-small cell lung cancer patients treated with stereotactic body radiotherapy: A matched-pair study

Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold model

Editorial comment

Effect of Prostate-specific Antigen Screening on Metastatic Disease Burden 10 Years After Diagnosis ⬇️

Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy

Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer

Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity

Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database

External beam radiotherapy followed by 90Y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma.

Five year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation therapy or permanent seed implantation

HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study

High-dose-rate endobronchial brachytherapy for recurrent airway obstruction from hyperplastic granulation tissue

Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer

Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience

Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes

Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus-negative head and neck cancer

Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy

Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone.

Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate

Improved biochemical relapse-free survival for patients with large/wide glands treated with prostate seed implantation for localized adenocarcinoma of prostate.

Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome

In Regard to Viani et al.

In Reply to Morris and Tyldesley.

Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy

Influence of zonal dosimetry on prostate brachytherapy outcomes

Informed consent conversations and documents: A quantitative comparison.

Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.

Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience.

Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience.

Late toxicity after intensity modulated and image guided radiation therapy for localized prostate cancer and post-prostatectomy patients.

Long-Term Efficacy and Toxicity of Low-Dose-Rate ¹²⁵I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer.

Lung stereotactic body radiation therapy: regional nodal failure is not predicted by tumor size.

Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases

Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.

Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial Design.

Modern outcomes of inflammatory breast cancer.

Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.

Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity

Never too old: A single-institution experience of stereotactic body radiation therapy for patients 90 years and older with early stage lung cancer.

No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients

Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy

Outcomes for prostate glands >60 cc treated with low-dose-rate brachytherapy

Outcomes in Organ Transplant Recipients With Prostate Cancer Treated With Radiotherapy

PSA bounce and biochemical failure after brachytherapy for prostate cancer: a study of 820 patients with a minimum of 3 years of follow-up

PSA bounce predicts early success in patients with permanent iodine-125 prostate implant

PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time

Perineural invasion on prostate needle biopsy does not predict biochemical failure following brachytherapy for prostate cancer

Postoperative single-fraction radiation for prevention of heterotopic ossification of the elbow

Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific Mortality

Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.

Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)

Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer